Synthesis, structure analysis, and antibacterial activity of some novel 10-substituted 2-(4-piperidyl/phenyl)-5,5-dioxo[1,2,4]triazolo[1,5-b][1,2,4]benzothiadiazine derivatives

Bioorganic and Medicinal Chemistry Letters

Volumn 17, Issue 19, 2007, Pages 5400-5405

  Kamal, Ahmed ^a   Khan, M Naseer A ^a   Reddy, K Srinivasa ^a   Rohini, K ^a   Sastry, G Narahari ^a   Sateesh, B ^a   Sridhar, B ^a  

^a INDIAN INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Antibacterial activity; Aryl sulfonamides; Quantum chemical calculations; Triazolobenzothiadiazines; X ray crystallography

Indexed keywords

3 (N' PIPERIDINOYL)BENZOTHIADIAZINE HYDRAZIDE; 3 HYDRAZINO 4 METHYL 4H 1,2,4 BENZOTHIADIAZINE 1,1 DIOXIDE; ANTIINFECTIVE AGENT; BENZOTHIADIAZINE DERIVATIVE; ISONIPECOTIC ACID; TRIAZOLO[4,3 B][1,2,4]BENZOTHIADIAZINE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; CHEMICAL ANALYSIS; DRUG EFFICACY; DRUG INHIBITION; DRUG SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; NONHUMAN; QUANTUM CHEMISTRY; SPECTROSCOPY; STRUCTURE ANALYSIS; X RAY ANALYSIS;

ANTI-BACTERIAL AGENTS; BACILLUS SUBTILIS; BENZOTHIADIAZINES; CRYSTALLOGRAPHY, X-RAY; ESCHERICHIA COLI; INDICATORS AND REAGENTS; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PIPERIDINES; STRUCTURE-ACTIVITY RELATIONSHIP; SULFONAMIDES;

BACILLUS SUBTILIS; ESCHERICHIA COLI; NEGIBACTERIA; POSIBACTERIA;

EID: 34548569917     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2007.07.043     Document Type: Article

References (31)

1. Ford C.W., Zurenko G.E., and Barbachyn M.R. Curr. Drug Targets Infect. Discord. 1 (2001) 181
2. LapPlante K.L., and Rybak M.J. Expert Opin. Pharmacother. 5 (2004) 2321
3. Katzung B.G. Basic and Clinical Pharmacology. 6th ed. (1995), University of California, San Francisco
4. Joshi S., and Khosla N. Bioorg. Med. Chem. Lett. 52 (2003) 197
5. Joshi S., Khosla N., and Tiwari P. Bioorg. Med. Chem. 12 (2004) 571
6. Anand N. Sulfonamides and Sulfones. In: Wolff M.E. (Ed). Burger's Medicinal Chemistry and Drug Discovery (1996), John Wiley & Sons, New York 527-573
7. Supuran C.T., Scozzafava A., and Casini A. Med. Res. Rev. 23 (2003) 146
8. Scozzafava A., Owa T., Mastrolorenzo A., and Supuran C.T. Curr. Med. Chem. 10 (2003) 925
9. Weber A., Casini A., Heine A., Kuhn D., Supuran C.T., Scozzafava A., and Kiebe G. J. Med. Chem. 47 (2004) 550
10. Brown G.M. J. Biol. Chem. 237 (1962) 536
11. Huovinen P., Sundström L., Swedberg G., and Skold O. Antimicrob. Agents Chemother. 39 (1995) 279
12. de Tullio P., Dupont L., Francotte P., Counerotte S., Lebrun P., and Pirotte B. J. Med. Chem. 49 (2006) 6779
13. Di Bella M., Monzani A., Andrisano M.G., Fabio U., and Quaglio G.P. Farmaco [Sci] 34 (1979) 189
14. Di Bella M., Gamberini G., Tait A., Fabio U., and Quaglio G.P. Farmaco [Sci] 38 (1983) 466
15. Kamal A., Reddy K.S., Ahmed S.K., Khan M.N.A., Sinha R.K., Yadav J.S., and Arora S.K. Bioorg. Med. Chem. 14 (2006) 650
16. +.
17. Chandra J.N.N.S., Sadashiva C.T., Kavitha C.V., and Rangappa K.S. Bioorg. Med. Chem. 14 (2006) 6621
18. Joshi S., Khosla N., Khare D., and Sharda R. Bioorg. Med. Chem. Lett. 15 (2005) 221
19. Kamal A., Khan M.N.A., Reddy K.S., and Rohini K. Bioorg. Med. Chem. 15 (2007) 1004
20. Heindel N.D., Ko C.C.H., Birrer R.B., and Merkel J.R. J. Med. Chem. 15 (1971) 118
21. Gadad A.K., Mahajanshetti C.S., Nimbalkar S., and Raichurkar A. Eur. J. Med. Chem. 35 (2000) 853
22. Scozzafava A., and Supuran C.T. Eur. J. Med. Chem. 35 (2000) 299
23. Reddy A.V.N., Kamal A., and Sattur P.B. Indian J. Chem. B (1985) 1295
24. Pomarnacka E., and Gdaniec M. Bioorg. Med. Chem. 11 (2003) 1259
25. Halperin J.A., Natarajan A., Guo Y., Harbinski F., Fan Y.H., Chen H., Luus L., Diercks J., Aktas H., and Chorev M. J. Med. Chem. 47 (2004) 4979
26. 29 Anisotropic displacement parameters were included for all non-hydrogen atoms. All H atoms were included using a riding model. The final R value (R1) was 0.0326 for 4231 observed [I > 2σ(I)] reflections and 0.0357 for all 4639 reflections using 343 parameters, and goodness-of-fit was 1.041. Full crystallographic details of 10b have been deposited at the Cambridge Crystallographic Data Centre and allocated the deposition number CCDC 641916.
27. Gaussian 03, Revision C.02, Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.; Robb, M. A.; Cheeseman, J. R.; Montgomery, J. A.; Vreven, T. Jr.; Kudin, K. N.; Burant, J. C.; Millam, J. M.; Iyengar, S. S.; Tomasi, J.; Barone, V.; Mennucci, B.; Cossi, M.; Scalmani, G.; Rega, N.; Petersson, G. A.; Nakatsuji, H.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.; Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Klene, M.; Li, X.; Knox, J. E.; Hratchian, H. P.; Cross, J. B.; Adamo, C.; Jaramillo, J.; Gomperts, R.; Stratmann, R. E.; Yazyev, O.; Austin, A. J.; Cammi, R.; Pomelli, C.; Ochterski, J. W.; Ayala, P. Y.; Morokuma, K.; Voth, G. A.; Salvador, P.; Dannenberg, J. J.; Zakrzewski, V. G.; Dapprich, S.; Daniels, A. D.; Strain, M. C.; Farkas, D. K.; Malick, A. D.; Rabuck, K.; Raghavachari, J. B.; Foresman, J. V.; Ortiz, Q.; Cui, O.; Baboul, A. G.; Clifford, S.; Cioslowski, J.; Stefanov, B. B.; Liu, G.; Liashenko, A.; Piskorz, P.; Komaromi, I.; Martin, R. L.; Fox, D. J.; Keith, T.; Al-Laham, M. A.; Peng, C. Y.; Nanayakkara, A.; Challacombe, M.; Gill, P. M. W.; Johnson, B.; Chen, W.; Wong, M. W.; Gonzalez, C.; Pople, J. A. Gaussian, Inc., Pittsburgh, PA, 2003.
28. Prescott, L. M.; Harley, J. P.; Klein, D. A. Microbiology, 5th edition. The Mc. Graw-Hill companies. Inc 1221: Avenue of the Americas, New York, NY, 10020, 2002, Chapter 35, pp 805-825.
29. -1) on the agar surface of the culture plates. The plates were incubated at 35 °C for 24 h for zone of inhibition, if any, around the disks. Lowest concentration of the test substance exhibiting no visible growth of bacteria on the plate was considered to be minimum inhibitory concentrations. Sulfanilamide and sulfadiazine were used as positive controls whereas, the equivalent amount of solvent (DMF) did not exhibit any activity in the assay.
30. SMART & SAINT. Software Reference manuals. Versions 5.625 &, 6.28a Bruker Analytical X-ray Systems Inc.: Madison, Wisconsin, U.S.A., 2001.
31. Sheldrick G.M. SHELXS97 and SHELXL97, Programs for Crystal Structure Solution and Refinement (1997), University of Gottingen, Germany